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Perfusion bioreactor systems have shown to be a valuable tool for the in vitro 
development of 3D cell-carrier constructs. Their use for cell expansion is however much 
less explored. Since maintenance of the initial cell phenotype is essential in this process, 
it is imperative to get an insight in the bioreactor-related variables determining cell fate. 
Therefore, this study investigated the influence of fluid flow induced shear stress on the 
proliferation, differentiation and matrix deposition of human periosteal derived cells in 
the absence of additional differentiation inducing stimuli. 120 000 cells were seeded on 
additive manufactured 3D Ti6Al4V scaffolds and cultured up to 28 days at different 
flow rates ranging between 0.04 and 6 ml/min. DNA measurements showed on average 
a threefold increase in cell content for all perfused conditions in comparison to static 
controls whereas the magnitude of the flow rate did not have an influence. Contrast-
enhanced nanofocus X-ray computed tomography showed substantial formation of an 
engineered neo-tissue in all perfused conditions, resulting in a filling up to 70% of the 
total internal void volume and no flow-rate dependent differences were observed. The 
expression of key osteogenic markers such as RunX2, OCN, OPN and Col1 did not 
show any significant changes in comparison to static controls after 28 days of culture, 
with the exception of Osx at high flow rates. We therefore concluded that, in the 
absence of additional osteogenic stimuli, the investigated perfusion conditions increased 
cell proliferation but did not significantly enhance osteogenic differentiation thus 
allowing for this process to be used for cell expansion.  
Keywords: bioreactor, perfusion, human periosteal derived cells, tissue engineering, 
cell expansion, nano CT, 3D 
  
1. Introduction 
The development of cell-based regenerative therapies to treat defects in the body is 
rapidly evolving (Martin et al. 2011; Martin et al. 2012). However, the translation of 
these techniques to a clinical setting still remains a major challenge due to suboptimal 
cell culture strategies leading to low yields of progenitor cells (Rodrigues et al. 2011). 
To address this, the development of robust processes using three dimensional (3D) 
bioreactor culture systems is a promising prospective (Grayson et al. 2004; Martin et al. 
2004; Haycock 2011; Rodrigues et al. 2011; Jakob et al. 2012; Salter et al. 2012). 
Bioreactors play a crucial role in establishing and maintaining 3D cell culture, 
controlling and monitoring physicochemical parameters in the system as well as 
automating manual procedures (Martin et al. 2010). Next to this, these systems allow to 
exert controlled mechanical stimuli such as hydrostatic pressure and shear stress (SS) on 
the developing construct (i.e. combination of a 3D carrier and cells/extracellular matrix 
(ECM)), which can be used to guide cell behaviour (McCoy and O'Brien 2010; Salter et 
al. 2012).  
Bioreactor facilitated stem cell expansion has already been achieved using multiple 
systems ranging from multi-layered cell factories to micro-carriers in stirred tank 
bioreactors (Jung et al. 2012). Different groups have already shown that the stem cell 
phenotype can be maintained in these systems despite the external hydrodynamic 
stresses applied on the cells by fluid flow during culture (Hewitt et al. 2011; Chang et al. 
2012; Jung et al. 2012). However, despite the 3D shape of the carriers used in these 
systems, cells predominantly grow in a monolayer which does not reproduce the native 
environment of the cells (Haycock 2011). Additionally, the use of these systems does 
not stimulate ECM formation although its presence in a 3D architecture has been shown 
to restrain spontaneous differentiation and preserve differentiation potential (Chen et al. 
2007). The shortfalls of these 3D culture systems can be addressed using a 3D perfusion 
bioreactor system. 
Next to enhancing the mass transport in the culture system, the combination of a 3D 
carrier and volumetrically controlled mass transport through perfusion has the potential 
to guide cell fate in function of culture conditions applied. In a range between 10-4 Pa 
and 10-1 Pa the SS exerted by the fluid flow on the developing construct has already 
been shown to have an enhancing effect on both osteogenic differentiation and 
mineralised matrix deposition, when the fluid flow is used as an additional stimuli 
combined with osteogenic inductive medium (Goldstein et al. 2001; Bancroft et al. 
2002; Cartmell et al. 2003; Gomes et al. 2003; Sikavitsas et al. 2003; Hosseinkhani et 
al. 2005; Grayson et al. 2008; Grayson et al. 2010; McCoy and O'Brien 2010; Fisher 
and Yeatts 2011; Grayson et al. 2011; Liu et al. 2012; McCoy et al. 2012; Salter et al. 
2012). However, when the bioreactor system is intended to be used for a cell population 
expansion rather than the development of TE constructs containing differentiated cells, 
the maintenance of the progenitor phenotype is essential. Although the use of different 
perfusion regimes such as the use of intermittent shear stress in normal growth medium 
affects the behaviour of bone marrow derived Mesenchymal stem cells (MSCs) (Kim 
and Ma 2012), the expansion of a Mesenchymal progenitor cell population in the 
presence of SS with maintenance of its phenotype has proven to be possible 
(Scherberich et al. 2007). Also substrate specific interactions have the potential to 
trigger specific cell responses to external stimuli (Grayson et al. 2011), explaining the 
large variation in specific cell responses to SS reported in literature (McCoy and 
O'Brien 2010; Fisher and Yeatts 2011). Therefore, it is required to determine the effect 
of a bioreactor culture on the proliferation and differentiation of a targeted cell 
population for specific combinations of SS and carrier material and structure. 
Human periosteal derived cells (hPDCs) obtained from periost biopsies contain 
osteochondro-progenitor cell populations (De Bari et al. 2006; Eyckmans and Luyten 
2006; Marolt et al. 2010). Their multi-lineage differentiation potential, phenotypical 
stability, high proliferation and accessibility make these cells a suitable cell source for 
bone tissue engineering (Hutmacher and Sittinger 2003; De Bari et al. 2006; Eyckmans 
and Luyten 2006; Agata et al. 2007; Ringe et al. 2008; Marolt et al. 2010). Several 
studies have already demonstrated the osteoinductive potential of these cells when 
implanted in vivo (Agata et al. 2007; Marechal et al. 2008; Roberts et al. 2011), and 
they are further being used for the development of tissue engineered bone products 
(Chai et al. 2012a; van Gastel et al. 2012a; van Gastel et al. 2012b). The use of 
periosteal derived cells in bioreactor systems and concomitantly the effect of such a 
system on the osteogenic differentiation of this cell population, is still very limited 
(Matziolis et al. 2006; Papantoniou et al. 2013a). 
In order to determine the potential of using a perfusion bioreactor system for the 
expansion of this progenitor cell population, the goal of this study was to determine the 
influence of perfusion on the in vitro proliferation, differentiation and matrix formation 
of hPDCs in the absence of differentiation inducing medium. hPDCs were cultured on 
inert Ti6Al4V porous scaffolds at different flow rates corresponding to the range of SS 
values used in literature and proliferation was evaluated in function of the applied SS 
based on DNA content. Thereafter the influence of two levels of SS, reported to 
respectively have a proliferation enhancing or osteogenic inductive effect, on the cell 
behaviour was determined and compared with static 3D culture. Real time PCR (RT-
PCR) was employed to analyse gene expression in combination with the analysis of the 
proliferation. Contrast enhanced nanofocus X-ray computed tomography (CE-nanoCT) 
was employed in combination with Live/Dead staining to visualise and quantify the 3D 
dynamics of cell growth and extracellular matrix deposition.    
 
2. Materials and methods 
2.1 Ti6Al4V Scaffolds 
Regular, 3D additive manufactured Ti6Al4V scaffolds (Ø = 6 mm, h = 6 mm) were 
produced in-house using selective laser melting based on a diamond shaped unit cell 
(Van Bael et al. 2011; Pyka et al. 2012) (Fig. 1.A). The total volume of the scaffolds 
was 166 ± 3 mm³, the available volume 130 ± 5 mm³ and the available surface 7.5 ± 0.6 
mm² as determined with nanoCT (Kerckhofs et al. 2013). Prior to use, scaffolds were 
ultrasonically cleaned for 10 min consecutively with acetone, ethanol and distilled water. 
Subsequently they received an alkali treatment with 5M sodium hydroxide (Sigma-
Aldrich) at 60°C for 24 hours, were rinsed with distilled water, and finally sterilised in a 
steam autoclave. Prior to cell seeding, all scaffolds were pre-wetted by vacuum 
impregnation in cell culture medium for 2 h in a humidified incubator at 37°C, and 
dried overnight in a non-humidified incubator (Impens et al. 2010; Papantoniou et al. 
2013a; Papantoniou et al. 2013b; Zhou et al. 2013). 
2.2 Fluid flow modelling 
In order to determine the SS correlated with the volumetric perfusion velocity and hence 
select a relevant range of flow rates, fluid flow modelling using computational fluid 
dynamics (CFD) was used as described by Truscello et al., 2012. Due to the 
symmetrical design of the scaffold the calculations were limited to one geometrical unit 
cell. A 3D geometrical model of a scaffold unit cell was created and meshed in the 
ACIS-based solid modeller Gambit 2.2 (Fluent). The mesh was refined until the 
solution was stable (mesh independent) and contained 750 000 elements which were 
sized to 30 µm³. To determine velocity fields and the related SS in the scaffold the finite 
volume code Fluent 6.3 (Fluent) was used. The culture medium was considered to be an 
incompressible and homogeneous Newtonian fluid with properties equal to water 
(viscosity: 10-3 Pa s, density: 103 kg/m3, temperature: 37 °C). Since the Reynolds 
number was lower than 1 the correlation between the flow rate and the SS was linear. 
Therefore the correlation between the flow rate and the SS was determined for one flow 
rate and thereafter extrapolated to the range of interest. A constant velocity of 2.36 
mm/s was assigned to the inlet, corresponding to a volumetric flow rate of 4 ml/min. 
No-slip conditions were applied to the walls of the scaffolds, symmetry conditions to 
the lateral surfaces and a zero gauge pressure was set at the outlet. The flow problem 
was described with steady-state Navier-Stokes equations.  
2.3 hPDC culture 
hPDCs were isolated from periosteal biopsies of different donors as described 
previously (Eyckmans and Luyten 2006). This procedure was approved by the ethics 
committee for Human Medical Research (KU Leuven) and with patient informed 
consent. hPDCs were expanded in Dulbecco’s modified Eagle’s medium with high-
glucose (Invitrogen) containing 10% foetal bovine serum (Gibco), 1% sodium pyruvate 
(Invitrogen) and 1% antibiotic–antimycotic (100 units/mL penicillin, 100 mg/mL 
streptomycin, and 0.25mg/mL amphotericin B; Invitrogen). The cells were seeded at 5 
700 cells/cm² and passaged at 80 % – 90 % confluence. Prior to the 3D culture 
experiments cells were harvested using Triple Express (Invitrogen) and drop-seeded by 
a single drop onto the scaffolds at a density of 200 000 cells per 60µl drop as performed 
in earlier studies (Papantoniou et al. 2013a; Papantoniou et al. 2013b; Zhou et al. 2013). 
45 min after seeding 60 µl culture medium was added and 135 min later the medium 
volume was topped up to 1 ml. Scaffold-cell constructs (further mentioned as constructs) 
were incubated overnight in standard culture conditions (37°C, 5% CO2, 95% relative 
humidity). Since the seeding process resulted in homogenous and reproducible seeding 
efficiencies in earlier experiments (~60%) this was not assessed separately in this work 
(Papantoniou et al. 2013a; Papantoniou et al. 2013b). This seeding procedure resulted in 
an initial cell density of 17 100 cells/cm² or 7*105 cells/cm³. 
For the initial flow rate screening 5 different values (0.04, 0.25, 1, 4 and 6 ml/min) were 
applied, corresponding with a SS range of 5.6*10-4 Pa to 8.4*10-2 Pa, thereby covering 
the range of SS reported in literature (McCoy and O'Brien 2010). 30 scaffolds were 
seeded as described before (5 scaffolds per flow rate and 5 as static control). After the 
overnight static incubation, the constructs were transferred to a 12 well plate containing 
3ml culture medium/well for static culture or to an in-house developed bioreactor 
system. This system contained in total 13 ml of culture medium for perfusion culture of 
which 3 ml was located in the circuit and the remaining 10 ml in the medium reservoir. 
Medium was refreshed every two days either by attaching a new medium reservoir 
containing 10 ml of fresh culture medium or by manually replacing the 3 ml of culture 
medium for the static constructs. Continuous perfusion was applied for a total duration 
of 21 days.(Papantoniou et al. 2013a; Papantoniou et al. 2013b; Zhou et al. 2013).  
For the time point experiment 54 scaffolds were seeded and afterwards divided in 3 
groups for static culture and perfusion at low and high flow rate (0.04 ml/min and 4 
ml/min) corresponding with SS values reported to have a proliferation of differentiation 
enhancing effect in different systems (McCoy and O'Brien 2010). Samples were taken 
at 14, 21 and 28 days. Time points were chosen to allow for the different stages of 
possible osteogenic differentiation and matrix deposition to occur. 
As a positive control for mineralisation constructs were cultured for 21 days at the high 
flow rate using a bioinstructive medium based on normal growth medium with the 
addition of 6 mM Ca2+, 4 mM Pi and 0.05 ng/ml ascorbic acid (Chai et al. 2012b; 
Papantoniou et al. 2013a). 
2.4 DNA measurement 
The DNA content was determined using a highly quantitative and selective DNA assay 
(Quant-iTTM dsDNA HS kit, Invitrogen). The methods used were developed and 
optimised for combined DNA measurement and RNA extraction from 3D constructs 
(Chai et al. 2012a; Chen et al. 2012; Papantoniou et al. 2013a). The constructs were 
rinsed with PBS and lysed in 350 µl RLT lysis buffer (Qiagen) supplemented with 3.5 
µl β-mercaptoethanol after which the lysed samples were vortexed for 60 s and stored at 
-80°C. Prior to analysis, the samples were thawed at room temperature and spun down 
for 1 min at 13 000 rpm. 10 µl of the sample was diluted in 90 µl milliQ water after 
which the DNA content was quantified with a Qubit® Fluorometer (Invitrogen) as 
described by Chen et al., 2012. 
2.5 Quantitative PCR 
For the time point experiment, RNA was extracted from 4 random, representative 
constructs for each culturing condition and time point using the RNeasy mini kit 
(Qiagen) and quantified using a Nanodrop ND-1000 spectrophotometer (Thermo 
Scientific). Complementary DNA was synthesised using the RevertAid H Minus First 
Strand complementary DNA synthesis kit (Fermentas). Sybr green quantitative 
polymerase chain reaction was performed for different key osteogenic and chondrogenic 
markers (Sox9, Col1, RunX2, OCN, OPN, OSX and BSP (Chai et al. 2012a)) and 
compared to HPRT (HPRT-F, 5’-TGAGGATTTGGAAAGGGTGT-3’; HPRT-R, 5’-
GAGCACACAGAGGGCTACAA-3’). The PCR reaction was cycled in a Rotor-Gene 
sequence detector (Qiagen) as follows: 95 °C for 3 min, 40 cycles of 95 °C for 3 s and 
60 °C for 60 s. Differences in gene expression were determined relatively in comparison 
to HPRT and shown as 2-ΔCT.  
For the constructs cultured with or without bioinstructive mineralisation medium for 21 
days the expression of Sox9, OCN, OPN and OSX was determined. Differences in gene 
expression were shown relative to HPRT expression and to the static control (2-ΔΔCT). 
2.6 Contrast-enhanced nanofocus computed tomography (CE-nanoCT) 
CE-nanoCT was performed on two random, representative constructs for each time 
point and culture condition as described earlier (Papantoniou et al. 2013b). The 
constructs were fixed in 4% paraformaldehyde (Sigma) for two hours and stored in PBS 
prior to analysis. Hexabrix® 320 (Guerbet) was used as a contrast agent to visualise the 
neo-tissue formed in the construct (Papantoniou et al. 2013b). As the Hexabrix® is an 
equilibrium contrast agent it will equally infiltrate all non-negatively charged tissues 
and thereby enable the visualisation of the radio-transparent neo-tissue in the opaque 
Ti6Al4V structure. 
A Phoenix NanoTom S (GE Measurement and Control Solutions) with a 180 kV/15 W 
high-performance nanofocus X-ray tube was used to perform the CE-nanoCT. A 
tungsten target was operated at a voltage of 90 kV and a current of 170 µA. An 
aluminium and copper filter, both 1 mm thick, were used to reduce beam hardening and 
metal artefacts. The exposure time was 500 ms, a frame averaging of 1 and image skip 
of 0 were applied, resulting in a scanning time of 20 min. The reconstructed images had 
an isotropic voxel size of 3.75 µm. 
2.7 3D visualisation, image processing and analysis 
CTAn (Bruker micro-CT) was used for image processing as described by Papantoniou 
et al., 2013b. Briefly, the neo-tissue was separated from the background noise and the 
scaffold using a 2-level Otsu thresholding method (Otsu 1979), resulting in a greyscale 
image containing 3 fractions, respectively background, neo-tissue and scaffold material. 
To analyse the volume of the Ti6Al4V scaffolds the resulting greyscale dataset was 
thresholded to obtain binary images representing the scaffold. In order to subsequently 
reduce the influence of the partial volume effect, edge effects and metallic artefacts 
introduced by the presence of the Ti6Al4V scaffold while analysing the neo-tissue 
volume, the binarised images for the scaffold were dilatated by two voxels and 
subtracted from the region of interest for further analysis. The neo-tissue fraction within 
the new region of interest was then binarised and the noise was removed by removing 
black speckles smaller than 500 voxels and white speckles smaller than 2 000 voxels. 
To solidify the resulting structure, a ’closing’ operation (~ 2 voxels) was performed on 
the resulting images, providing the images used for the 3D analysis of the neo-tissue 
volume. 
2.8 Live/Dead assay 
A Live/Dead viability/cytotoxicity kit (Invitrogen) was used to evaluate qualitatively 
cell viability and cell distribution by optical microscopy. For each culture condition two 
random, representative constructs were imaged of which one was subsequently used for 
CE-nanoCT and one for DNA measurement and RNA extraction. Constructs were 
rinsed with 1 ml PBS after which they were incubated in the staining solution (0.5 µl of 
a 4mM Calcein AM in anhydrous DMSO solution and 2 µl of a 2mM Ethidium 
Homodimer in DMSO/H20 (1:4, v:v) in 1 ml PBS) for 20 min in normal cell culture 
conditions. The constructs were imaged using a Leica M165 FC microscope. 
2.9 Alizarin red staining 
Constructs cultured for 21 days with normal growth medium or bioinstructive medium 
were fixed in 4% paraformaldehyde and stored in PBS prior to staining. Staining was 
performed with a 2% Alizarin Red S (Sigma) solution in water (pH 4.2) for 1 hour at 
room temperature during continuous gentle agitation. Samples were subsequently rinsed 
with demineralised water until no additional staining was removed from the constructs 
after which they were imaged using a stereo microscope (Leica M165 FC). 
2.10 Statistical analysis 
Student t-test was performed to analyse significant differences between groups using 
Statistica 7 (Statsoft). A p-value < 0.05 was considered significant. 
3. Results 
3.1 Shear stress range 
 CFD was used to determine the initial SS which the fluid exerted on the constructs in 
order to compare our results with other reports (Grayson et al. 2011; Kim and Ma 2012). 
Since the scaffold design consists of a repetition of a regularly shaped diamond unit cell 
(Fig. 1.A), the calculations were performed for only one unit cell (Truscello et al. 2012). 
Figs. 1.B-C show a 3D visualisation of the SS on a scaffold unit cell and the 
corresponding histogram of the relative SS distribution within the unit cell. Fig. 1.D 
shows the initial average CFD-calculated SS based on the experimentally used flow 
rates. The obtained distribution could be extrapolated for the other flow rates used since 
fluid flow remained laminar in the used range. 
3.2 Proliferation 
The use of different flow rates did not significantly influence the DNA content of the 
constructs after 21 days of dynamic culture in growth medium (Fig. 2.A). However, 
analysis of all perfused constructs cultured for 21 days at different flow rates showed 
that the DNA content of the constructs cultured in perfusion was on average 2.75 ± 0.27 
fold increased in comparison with the static control. To get a better understanding of the 
time-dependent influence on hPDC proliferation of a constant volumetric flow rate in 
combination with a morphological changing matrix, which resulted in a time dependent 
increase in SS, the 0.04 ml/min and 4 ml/min flow rate conditions were selected and 
compared to the static culture for 14, 21 and 28 days. For all time-points the perfused 
conditions showed a significant increased DNA content in comparison to the static 
control. However, the static control as well as the perfused conditions did not show any 
significant time dependent changes from 14 up to 28 days (Fig. 2.B), although an 
increasing trend was still observed for the perfused constructs.  
Based on our in-house 2D hPDC expansion database an average cell expansion of 2.9 ± 
0.65 was determined in comparison to the initial cell density for a 7 day expansion 
period or 8.4 ± 2.6 in 14 day when cells are replated according to standardised cell 
expansion protocols (n=20). 
3.3 Live/Dead staining 
Cell distribution at the periphery of the constructs was visualised using the Live-Dead 
viability/cytotoxicity kit (Fig. 3.). For both the statically cultured and the 0.04 ml/min 
perfused samples the construct was fully covered with cells after 21 days of culture. For 
the high flow rate (4 ml/min) the cell coverage of the outer surfaces did not seem to 
increase over time for the imaged time points. A clearly less dense coverage of the 
surface was observed in comparison with the two previously described conditions. 
There were no significant amounts of dead cells observed in any of the examined 
conditions.  
3.4 3D matrix image analysis by CE-nanoCT 
CE-nanoCT using Hexabrix® as contrast agents was used to visualise and quantify in 
3D the neo-tissue formed in the constructs. Fig. 4 shows axial 2D cross-sections 
representative for the entire construct for 0.04 and 4 ml/min as well as the static control 
for different time points. In the raw images (left 3 columns) the white zones represent 
the scaffold structure, while the delineated grey features represent the neo-tissue in the 
constructs. The binarised images (right) show the quantified neo-tissue fraction in white. 
In correspondence with the Live/Dead staining shown in Fig. 3., the outer surface of the 
statically cultured constructs was nearly completely covered with cell-matrix after 14 
days, which is visible as a thin line with a lighter shade of grey on the images in Fig. 4 
as indicated with the arrows. Increasing the static culture duration did not result in a 
significant increase in cell-matrix volume for these constructs. The perfusion cultured 
constructs showed that the morphology of the cell-matrix formed was influenced by the 
culture condition. Instead of forming a cell sheet on the outer edges of the construct as 
was the case for the static control, cell-matrix was formed throughout the entire scaffold 
resulting in a much denser and more filled construct as was also observed by DNA 
analysis (Fig. 2.B). In both the 0.04 ml/min and 4 ml/min perfused culture the 
Hexabrix® based images showed that the cell-matrix was gradually filling up the 
available space in the construct.  
As reported earlier, the amount of cell-matrix present in the statically cultured 
constructs was too low to be quantified (Papantoniou et al. 2013b). As shown in Figure 
4 the neo-tissue developed in these constructs was fibrous in appearance and was only 
located in thin strands (average diameter of about 5 µm as determined with DataViewer, 
Bruker MicroCT) at the outer edges of the constructs. Although most of these structures 
can be visually discriminated in the CE-nanoCT images, the limited contrast difference 
between the stained neo-tissue and the background did not allow to accurately segment 
both from each other, resulting in an erroneous quantification of the neo-tissue volume. 
Therefore, quantitative analysis of the cell-matrix volume was performed only on the 
perfused constructs. In Fig.5., the relative filling volume, determined using Hexabrix® 
as a contrast agent, was normalised to DNA content. For the high flow rate, a stronger 
increase after 21 days of culture was observed compared to the low flow rate where this 
increase was only observed after 28 days indicating a difference in matrix deposition 
kinetics. At the final time-point however, no differences in deposited matrix per cell 
was present. 
3.5 Gene expression analysis 
Finally gene expression analysis was performed to assess the influence of the different 
culture conditions on cell differentiation (Fig 6.). For the statically cultured constructs a 
significant down regulation of the Col1 expression was observed in function of time. 
The 14 and 21 day expression of Col1 in the perfused conditions was also down-
regulated in comparison to the static constructs but this difference was no longer present 
at the 28 day time point. For RunX2 the expression remained stable in function of time 
for the static constructs and no differences were observed between the static and 
perfused conditions. For the low flow rate a significant increase was observed between 
day 14 and 28. For the high flow rate this increase was observed at the 21 day time 
point, although it was no longer present at the final day 28 time point. In the case of 
OCN no significant differences were observed between the static controls and both 
perfused conditions. At day 14 a higher expression was observed for the low flow rate 
in comparison to the high flow rate but this difference was no longer observed at later 
time points. Except for the low flow rate at day 14 no differences were observed in OPN 
expression between the static control and the perfused conditions. Although a time 
dependent increase was observed for the low flow rate, OPN expression was 
significantly higher for the high flow rate in comparison to the low flow rate. BSP 
showed a time-dependent increase in both perfused conditions resulting in a 
significantly higher expression in comparison to the static control at day 28. No 
significant differences between the perfused conditions were observed. Sox9 expression 
decreased significantly over time in the static control. In both perfused conditions Sox9 
expression was significantly lower at day 14 and 21 but this difference was no longer 
observed at day 28. OSX expression showed a time dependent decrease in the static 
control. Except at day 14 no differences were present between the static control and the 
low flow rate condition. The high flow rate showed a significantly higher expression in 
comparison to the low flow rate (all time points) and to the static control (after 21 and 
28 days). 
4. Discussion 
Perfusion bioreactor systems show great promise as a  tool for automated 3D cell 
expansion and their use will be essential for the clinical implementation of current tissue 
engineering and regenerative medicine strategies (Martin et al. 2010; Fisher and Yeatts 
2011; Salter et al. 2012). Therefore, it is imperative to understand the influence of the 
process environment on the behaviour and properties of the cell populations expanded 
in these systems and define suitable operating conditions which support cell expansion 
while maintaining a progenitor cell phenotype. The present study used hPDCs seeded 
on a Ti6Al4V scaffold in a perfusion bioreactor system to determine its potential for 
cell expansion by evaluating the influence of flow-induced SS on the proliferation, 
differentiation and extracellular cell-matrix deposition in the absence of additional 
differentiation-inducing stimuli such as osteogenic inductive medium. 
3D perfusion bioreactor culture has been extensively used for the production of bone TE 
constructs and has shown to significantly increase proliferation, differentiation and 
mineralised matrix deposition in comparison to static controls (McCoy and O'Brien 
2010; Fisher and Yeatts 2011). Additionaly, SS dependent increases in proliferation and 
mineralisation have been reported for MSCs in combination with osteogenic medium 
(Bancroft et al. 2002; Cartmell et al. 2003; Sikavitsas et al. 2003; McCoy and O'Brien 
2010). Additionally, the use of intermittent shear stresses exerted on the a construct 
developing in normal growth medium resulted in the significant induction of an 
osteogenic phenotype in comparison to the continuous shear conditions, although no 
comparison with a static control was made here (Liu et al. 2012). In correspondence 
with this literature data, our work showed that perfusion significantly increased the cell 
number on the Ti6Al4V scaffolds in comparison to the static control (Fig. 2.A), as both 
dynamic conditions resulted in a significant increase in DNA content in comparison to 
the static control for all time points. The enhanced mass transport present in a perfusion 
setup in comparison to the static setup will provide an optimal nutrient supply to the 
entire construct, thereby enabling all the cells in the construct to proliferate under more 
optimal conditions. This was confirmed with the CE-nanoCT which shows that the 
developed neo-tissue is only present at the outer edges of the statically cultured 
constructs while in both perfused conditions the neo-tissue is deposited uniformly 
throughout the entire construct. As the use of a higher flow rate did not significantly 
improve the nutrient supply to the developing constructs, the absence of correlated 
changes in proliferation could be explained, as also reported earlier for similar systems 
using osteogenic medium supplements (Sikavitsas et al. 2003; Dai et al. 2009; Grayson 
et al. 2011).  
An average cell density increase of 3.6 ± 0.6 times, with respect to the static constructs 
or an 8.4 ± 1.7 fold increase in relation to the initial cell density were observed after 28 
days (Figure 2.B). These expansion rates were not significantly different from those 
observed in the standard 2D culture at the 14 day time point for the high flow rate (8.4 ± 
2.6 for 2D  vs 7 ± 1.2 in the perfusion system), without the need for replating. For later 
time points the proliferation rate, based on the DNA measurement, in the 3D perfusion 
bioreactor setup decreased, due to the gradual filling and closing of the open spaces in 
the construct as shown in Fig. 4. In 2D culture systems a decrease in proliferation is also 
observed when cells are not replated prior to confluence, but for 2D static culture 
systems this phenomenon already occurs after 8 to 10 days resulting in an average cell 
expansion of 4 to 5 times. This shows that the perfusion bioreactor system performs at 
least as efficient as a standard 2D sub-culture system with regard to cell expansion, but 
not requiring manual intermediate trypsinisation and replating steps.  
Besides conventional, manual, 2D cell expansion, the use of micro carriers is often 
mentioned to be a promising technique for automated cell expansion despite the absence 
of a real 3D environment (dos Santos et al. 2011; Hewitt et al. 2011; Goh et al. 2013). 
In these systems 7 to 20 fold increases in cell number have been reported after already 7 
days of cell expansion resulting in significantly higher expansion rates in comparison to 
the 3D perfusion bioreactor system used for this work. However, the maximal cell 
density that could be obtained in micro-carrier based expansion systems is on average 
between 2*105 and 8*105 cells/cm³  (dos Santos et al. 2011; Hewitt et al. 2011; Goh et 
al. 2013) while, based on the DNA content and assuming an average of 8.9 pg 
DNA/cell as reported earlier (Zhou et al. 2013), the 3D perfusion system used in this 
work reached a cell density of 5 to 6*106 cells/cm³. This demonstrates that a higher cell 
number per volume unit can be obtained, thereby indicating their high cell expansion 
potential per volumetric unit. Additionally, current protocols for the 3D perfusion 
bioreactor system have not been optimised yet for cell expansion. Reducing the initial 
cell seeding density in the system from 7*105 cells/cm³ or 17 100 cells/cm² to the 
densities which are currently used for micro carrier expansion (10 to 20 fold lower 
(Hewitt et al. 2011)) could further increase the yield of the 3D perfusion bioreactor 
culture. 
Live/dead staining of the constructs showed that no the flow rate had no significant 
influence on the cell viability in the outer layers of the formed neo-tissue (Fig.3). The 
differences in DNA content between static and dynamically cultured constructs could 
not be visually confirmed. However, microscope-based live/dead staining is a line-of-
sight visualisation technique, allowing only observation of the peripheral part of the 
scaffold, hence a novel imaging technique, CE-nanoCT was used in order to monitor 
cell growth and provide quantitative volumetric information regarding cell and 
extracellular matrix distribution throughout the entire volume of the scaffold (Fig. 
4)(Papantoniou et al. 2013b). CE-nanoCT images showed a time dependent 3D filling 
of the scaffold void volume. For the static constructs cell-matrix was only situated on 
the outer edges of the construct as reported by other groups using destructive 2D based 
techniques such as histology (Ishaug et al. 1997; Bancroft et al. 2002; Sikavitsas et al. 
2003). In function of time not only was more cell-matrix deposited but also the amount 
of cell-matrix deposited per cell, as calculated based on the CE-nanoCT based images 
and the measured DNA content, increased for both flow rates as observed by the 
Hexabrix® based images (Fig. 4, Fig. 5. As higher SS has been reported to result in 
increased matrix deposition (Jaasma et al. 2008; Grayson et al. 2011), the increase in SS 
present in the developing constructs due to the filling of the available volume could 
explain the observed increase in matrix deposition per cell. Despite the difference in 
matrix deposition kinetics no differences in matrix deposition were observed for the 
different flow rates at the final timepoint.  
In this work initial SS values exerted on the developing constructs, as determined by 
CFD, ranged between 5.59*10-4 and 8.38*10-2 Pa. Although  in this range, enhanced 
osteogenic differentiation and collagen production has been previously reported for 
MSCs in combination with osteogenic medium (McCoy and O'Brien 2010) its influence 
in normal growth medium is not known. The SS values determined using CFD were 
based on the empty Ti6Al4V scaffold geometry. However, as observed by the 
experimental data, cell and matrix growth gradually filled up the internal volume of the 
Ti6Al4V scaffold, thereby significantly altering the flow environment. The increase in 
cell-matrix volume will reduce the volume available for the fluid to flow through, 
thereby increasing the flow rate of the medium and the correlated SS. Calculated SS 
values will therefore more closely represent those SS values that hPDCs will experience 
during the initial period of the bioreactor culture and serve mainly as a reference for 
comparison with  literature data in which a similar approach was used (Bancroft et al. 
2002; Sikavitsas et al. 2003; Kim and Ma 2012; Liu et al. 2012). In future work the 
neo-tissue filling determined via CE-nanoCT as function of culture duration may be 
used as input for CFD modeling to obtain dynamic SS information to which the cells are 
actually exposed during the expansion process. 
To further assess the influence of flow rate on the hPDCs the expression of a range of of 
genes was analysed to determine cell commitment towards a specific lineage (Fig 6.). 
Results showed that Sox9 was significantly down-regulated for both perfusion 
conditions at day 14 and 21 in comparison to the static control, but that this was no 
longer the case at day 28 due to the gradual decrease observed in the static control. Sox9 
expression was already shown to be increased in a perfusion system in chondrogenic 
medium (Tigli et al. 2011) but, in correspondence with our findings, there were no 
reports of increased chondrogenic differentiation in the absence of biochemical inducers 
in a perfusion system. Therefore no additional chondrogenic markers were evaluated in 
this work. Different osteogenic markers, such as Col1, RunX2, OPN and OCN, showed 
limited time-dependent changes in expression. In accordance to previously reported data 
(Bjerre et al. 2008; Kim and Ma 2012), certain flow-rate-dependent changes in 
expression were observed, but perfusion as such did not have a significant influence on 
the expression of these key osteogenic markers as no differences between the static 
control and the perfused conditions were present (Fig 6.). Additionally, the limited 
observed time dependent changes in expression of these markers are negligible in 
comparison to what was reported earlier for induced osteogenic differentiation for this 
cell type (Chai et al. 2011). Despite that no significant changes were observed in the 
expression of ECM related genes such as Col1 and OCN significant differences in the 
ECM deposition per cell were observed between the different conditions. The culture of 
cells under shear stress has earlier been shown to potentially induce changes in 
posttranscriptional regulation of certain ECM proteins (Bjerre et al. 2008) and 
differences in the incorporation of secreted matrix proteins (Grayson et al. 2011). This 
indicates that SS can significantly influence the composition of the deposited neo-tissue 
in a 3D culture system without influencing gene expression, thus potentially explaining 
the differences in neo-tissue volume deposited in static versus the perfused conditions. 
BSP on the other hand showed, compared to the static control, an 8-fold time-dependent 
increase in expression in both perfused conditions. However, as shown by Grayson et al, 
2011  the combination of perfusion and osteogenic medium can result in a 100-fold 
increase in BSP expression after one week and even a 1 000-fold increase after 5 weeks 
of perfusion culture using MSCs (Grayson et al. 2011), indicating that the increase 
observed in our study is limited for both perfused conditions. For OSX, an important 
early osteogenic transcription factor (Kim and Ma 2012), a flow rate dependent increase 
in expression was observed. In the normal osteogenic differentiation cascade of events 
this increase would be preceded by an increase in RunX2, of which OCN is a 
downstream target, and followed by an increased expression of BSP and OCN (Lian et 
al. 2006; Franceschi et al. 2007; Kim and Ma 2012). This cascade of events was 
however not observed in the studied system. Although the expected initial increase of 
RunX2 in osteogenic differentiation could have occurred at an earlier time point and a 
subsequent increase in BSP expression was present no differences in OCN expression 
were detected. In the absence of the OCN increase, the increased OSX expression could 
be explained by cell lineage commitment rather than to full osteogenic differentiation.  
This was confirmed by comparing the expression of Sox9, OCN, OPN and OSX for 
constructs cultured for 21 days using normal growth medium and bioinstructive 
mineralisation medium (Figure 7.A). Although a significant lower Sox9 expression was 
detected in the normal constructs after 21 days, a 100-fold stronger decrease in 
expression was present in the induced constructs. For the OCN, OPN and OSX 
expression respectively a 12-, 90- and 6-fold increase in expression was detected for the 
induced constructs in comparison with the growth medium cultured. Alizarin red 
staining visually confirmed the presence of a mineralised matrix in the induced 
constructs (Figure 7.C), while this was not detected in the growth medium constructs 
(Figure 7.B). This further confirmed that expansion of the MSC like hPDC cell 
population in a perfusion bioreactor system does not result in significant osteogenic 
differentiation nor in an associated mineralised matrix deposition although there are 
indications of osteogenic lineage commitment as shown by the increased OSX and BSP 
expression.In conclusion, we can state that, for our experimental set-up, perfusion 
bioreactor culture resulted in expansion rates similar to those obtained in different 
validated cell expansion systems. Additionally, the system did not induce significant 
changes in the expression pattern of the osteogenic and chondrogenic markers analysed. 
Although small differences in the expression of certain markers were observed between 
different flow rates, these were limited in comparison to the reported increases in 
expression when using osteo- or chondro-inductive media in both static and perfused 
conditions as well as to changes in gene expression in the constructs cultured with 
bioinstructive mineralisation medium. Perfusion did however significantly increase cell 
proliferation and resulted in flow rate-dependent changes in matrix deposition kinetics. 
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 FIG. 1.: (A) Bright field image of a Ti6Al4V scaffold, (B) SS distribution on a scaffold 
unit cell for a perfusion velocity of 4 ml/min, (C) relative distribution of the SS on the 
scaffold unit cell for a perfusion velocity of 4 ml/min and (D) interstitial fluid velocity 
and average SS corresponding with the applied perfusion velocities. All calculations 
were performed on an empty scaffold, thus representing the initial SS present after cell 
attachment and prior to construct culturing.  
  
 FIG. 2. (A) DNA content of the constructs relative to the static control after 3 weeks of 
dynamic culture ( n=4 to 6), (B) DNA content of the constructs after 14, 21 or 28 days 
of culture in a static or perfused (0.04 ml/min and 4 ml/min) system (n=4, ***p<0.001, 
black bars show standard deviations of the mean). 
  
 FIG.3. Live/Dead staining of constructs for different culture regimes and durations. The 
green fluorescent dye shows all the living cells while the red dye visualises the nuclei of 
the dead cells. Scale bar is 1mm 
  
 FIG.4. Representative 2D CE-nanoCT cross-sectional images stained with Hexabrix® 
of the constructs cultured at different conditions and their corresponding processed 
images for 3 weeks of perfusion culturing. White arrows indicate cell-matrix in the 
static conditions. Scale bar is 1mm. 
  
 FIG.5. Relative filling of the scaffold determined with Hexabrix® normalised to cell 
content, $ indicates a significant difference between the two flow rates (p<0.05), *: 
0.05>p>0.01, **: 0.01>p>0.001 
  
  FIG.6. Gene expression of the cultured constructs by means of RT PCR for Col1, 
RunX2, OPN, OCN, BSP, Sox9 and OSX relative to HPRT. & indicates a significant 
difference with the corresponding time point of the static control (p<0.05), *: 
0.05>p>0.01, **: 0.01>p>0.001. (n=4). 
  
 Fig.7. (A) Gene expression of perfusion bioreactor cultured constructs with normal 
growth medium (Black) and mineralisation medium (Grey) for 21 days relative to 
HPRT and to the static control (ΔΔCT) by means of RT PCR for Sox9, OCN, OPN and 
OSX. $ shows relative to the static control. P<0.05, n=3 (B and C) Alizarin red staining 
of respectively normal growth medium and mineralisation medium cultured constructs 
after 21 days of culture. Scale bars are 1 mm 
 
